This inventor holds 1 USPTO granted patent. Top assignees: Shenyang Research Institute of Chemical Industry, Sinochem Corporation. Active years: 2018.
Company Filing History:
1 out of 20 
1 out of 16 
Years Active: 2018
Title: Innovations in Antitumor Drugs: The Contributions of Inventor Xiaoping Yang
Introduction
Xiaoping Yang, an accomplished inventor based in Liaoning, China, has made significant contributions to the field of pharmaceutical innovations, particularly in the development of antitumor drugs. With a keen focus on chemistry and medicinal applications, Yang holds one patent that showcases his dedication to advancing cancer treatment.
Latest Patents
Yang's patent entitled "Applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs" provides vital insights into innovative compounds aimed at combating various cancer types. The patent discloses the applications of compounds represented by general formula I, which demonstrate desirable antitumor activity, especially against leukemia strain HL-60, different lung cancer strains (A549, H157, H460, H520), bladder cancer (T24, J82), prostate cancer (LNCap, PC-3), and rectal cancer (HCT8, HCT116, RkO). The specification also outlines the definitions of the substituent groups in formula I, highlighting their potential in formulating new anticancer drugs.
Career Highlights
Throughout his career, Xiaoping Yang has had affiliations with reputable organizations, including Sinochem Corporation and Shenyang Research Institute of Chemical Industry Co., Ltd. These institutions have provided him with the platform to refine his skills and contribute to groundbreaking research in medicinal chemistry. His work within these organizations emphasizes his commitment to developing effective cancer therapies.
Collaborations
Yang has also worked alongside distinguished colleagues, including Changling Liu and Aiying Guan. These collaborations reflect a collective effort to pioneer innovations in the field of antitumor drug research, fostering an environment of shared knowledge and expertise.
Conclusion
Xiaoping Yang's innovative contributions to the field of antitumor drugs stand as a testament to the potential of chemical compounds in combating cancer. His patent reveals a promising direction for future drug development, highlighting the importance of continued research and collaboration in tackling this formidable disease. As the landscape of cancer treatment evolves, inventors like Yang are crucial to driving these advancements forward.